Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Amdocs (DOX) stock

Learn how to easily invest in Amdocs stock.

Amdocs Limited
NASDAQ: DOX - USD
SOFTWARE-INFRASTRUCTURE
$77.89
+$0.70 (+0.91%)

Amdocs Limited is a software-infrastructure business based in the US. Amdocs shares (DOX) are listed on the NASDAQ and all prices are listed in US Dollars. Amdocs employs 27,000 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Amdocs

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – DOX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Amdocs stock price (NASDAQ: DOX)

Use our graph to track the performance of DOX stocks over time.

Amdocs shares at a glance

Information last updated 2021-07-22.
Latest market close$78.10
52-week range$53.93 - $81.64
50-day moving average $78.94
200-day moving average $76.59
Wall St. target price$84.57
PE ratio 15.1412
Dividend yield $1.343 (1.73%)
Earnings per share (TTM) $5.10

Buy Amdocs shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Amdocs stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Amdocs price performance over time

Historical closes compared with the close of $78.1 from 2021-05-28

1 week (2021-07-13) N/A
1 month (2021-06-24) 1.21%
3 months (2021-04-20) N/A
6 months (2021-01-20) N/A
1 year (2020-07-20) N/A
2 years (2019-07-20) N/A
3 years (2018-07-20) N/A
5 years (2016-07-20) N/A

Is Amdocs under- or over-valued?

Valuing Amdocs stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Amdocs's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Amdocs's P/E ratio

Amdocs's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 15x. In other words, Amdocs shares trade at around 15x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Amdocs's PEG ratio

Amdocs's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.4425. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Amdocs's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Amdocs's EBITDA

Amdocs's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $785.5 million.

The EBITDA is a measure of a Amdocs's overall financial performance and is widely used to measure a its profitability.

Amdocs financials

Revenue TTM $4.2 billion
Operating margin TTM 13.86%
Gross profit TTM $1.4 billion
Return on assets TTM 5.84%
Return on equity TTM 18.64%
Profit margin 15.98%
Book value $28.23
Market capitalisation $9.9 billion

TTM: trailing 12 months

Shorting Amdocs shares

There are currently 2.4 million Amdocs shares held short by investors – that's known as Amdocs's "short interest". This figure is 2.8% down from 2.5 million last month.

There are a few different ways that this level of interest in shorting Amdocs shares can be evaluated.

Amdocs's "short interest ratio" (SIR)

Amdocs's "short interest ratio" (SIR) is the quantity of Amdocs shares currently shorted divided by the average quantity of Amdocs shares traded daily (recently around 735168.99696049). Amdocs's SIR currently stands at 3.29. In other words for every 100,000 Amdocs shares traded daily on the market, roughly 3290 shares are currently held short.

However Amdocs's short interest can also be evaluated against the total number of Amdocs shares, or, against the total number of tradable Amdocs shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Amdocs's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Amdocs shares in existence, roughly 20 shares are currently held short) or 0.0193% of the tradable shares (for every 100,000 tradable Amdocs shares, roughly 19 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Amdocs.

Find out more about how you can short Amdocs stock.

Amdocs's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Amdocs.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Amdocs's total ESG risk score

Total ESG risk: 20.97

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Amdocs's overall score of 20.97 (as at 12/31/2018) is pretty good – landing it in it in the 21st percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Amdocs is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Amdocs's environmental score

Environmental score: 6.71/100

Amdocs's environmental score of 6.71 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Amdocs is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Amdocs's social score

Social score: 15.33/100

Amdocs's social score of 15.33 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Amdocs is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Amdocs's governance score

Governance score: 10.44/100

Amdocs's governance score puts it squarely in the 6th percentile of companies rated in the same sector. That could suggest that Amdocs is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Amdocs's controversy score

Controversy score: 1/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Amdocs scored a 1 out of 5 for controversy – the highest score possible, reflecting that Amdocs has managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

Amdocs Limited was last rated for ESG on: 2019-01-01.

Total ESG score 20.97
Total ESG percentile 20.5
Environmental score 6.71
Environmental score percentile 6
Social score 15.33
Social score percentile 6
Governance score 10.44
Governance score percentile 6
Level of controversy 1

Amdocs share dividends

30%

Dividend payout ratio: 29.96% of net profits

Recently Amdocs has paid out, on average, around 29.96% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.85% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Amdocs shareholders could enjoy a 1.85% return on their shares, in the form of dividend payments. In Amdocs's case, that would currently equate to about $1.343 per share.

While Amdocs's payout ratio might seem fairly standard, it's worth remembering that Amdocs may be investing much of the rest of its net profits in future growth.

Amdocs's most recent dividend payout was on 22 July 2021. The latest dividend was paid out to all shareholders who bought their shares by 28 June 2021 (the "ex-dividend date").

Amdocs share price volatility

Over the last 12 months, Amdocs's shares have ranged in value from as little as $53.9349 up to $81.6396. A popular way to gauge a stock's volatility is its "beta".

DOX.US volatility(beta: 0.78)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Amdocs's is 0.7835. This would suggest that Amdocs's shares are less volatile than average (for this exchange).

Amdocs overview

Amdocs Limited, through its subsidiaries, provides software and services to the communications, cable and satellite, entertainment, and media industry service providers worldwide. The company offers a line of services designed for various stages of a service provider's lifecycle, including planning, delivery, implementation, and ongoing support and operations, such as end-to-end systems integration, managed, testing, cloud, digital business operations, and consulting services that addresses service providers business imperatives, including consumer experience and monetization, media and digital services, enterprise and connected society, open cloud networks, new domains and disruptions, and services and hybrid operations. It also provides revenue guard services designed to detect and resolve revenue leakage, fraud, and cyber fraud; and the BriteBill, a multi-channel bill presentment platform. In addition, the company offers advertising and media services for media publishers, TV networks, video streaming providers, advertising agencies, and service providers. Amdocs Limited was founded in 1988 and is headquartered in Chesterfield, Missouri. .

Frequently asked questions

What percentage of Amdocs is owned by insiders or institutions?
Currently 0.078% of Amdocs shares are held by insiders and 93.755% by institutions.
How many people work for Amdocs?
Latest data suggests 27,000 work at Amdocs.
When does the fiscal year end for Amdocs?
Amdocs's fiscal year ends in September.
Where is Amdocs based?
Amdocs's address is: 1390 Timberlake Manor Parkway, Chesterfield, MO, United States, 63017
What is Amdocs's ISIN number?
Amdocs's international securities identification number is: GB0022569080
What is Amdocs's CUSIP number?
Amdocs's Committee on Uniform Securities Identification Procedures number is: G02602103

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site